Finding the Right Dose of AD-211 for Knee Arthritis
Part of Bones, joints & muscles clinical trials.
This study tests different doses of a new medicine called AD-211 to find the safest and most effective amount for people with knee osteoarthritis (wear-and-tear damage in the knee joint). The goal is to help reduce pain and improve movement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have osteoarthritis (arthritis from wear and tear, not from an injury or disease) in at least one knee
- You are willing to sign a consent form showing you understand the study
- You do not have secondary osteoarthritis (arthritis caused by a past injury, infection, or another medical condition)
- You meet other specific health and medical history requirements the study team will review
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new knee injection called CX-011 to see if it can reduce pain and improve function in people with knee osteoarthritis. It may be a good option if you have tried other treatments without enough relief.
This study tests a new injection called 2107 to see if it helps reduce pain and improve function in people with mild to moderate knee osteoarthritis. If you're eligible, you'll receive the injection and be monitored for several months to see how it works.
This trial tests a new injection called AVD275 for people with knee osteoarthritis. It aims to see if the injection is safe and how it works in the body.
This trial studies ICM-203, a new treatment, to see if it is safe and if it can help symptoms in people with knee osteoarthritis. It mainly looks at safety and early signs of benefit for knee pain and function.
This study tests a new antibody drug (FB1003) for people with knee osteoarthritis pain. It will check if the drug is safe and helps reduce pain. You may be eligible if you have moderate to severe knee pain and are willing to temporarily stop your usual pain medications.
This trial tests an investigational drug, HRS-2129, for people with knee osteoarthritis who have moderate to severe pain. It aims to see if the drug is safe and effective at reducing pain.
Hear when a new Osteoarthritis of the Knees trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.